OSE Pharma Valuation
| OSE Stock | EUR 6.54 0.04 0.61% |
At this time, the company appears to be overvalued. OSE Pharma SA holds a recent Real Value of €5.55 per share. The prevailing price of the company is €6.54. Our model determines the value of OSE Pharma SA from inspecting the company fundamentals such as Operating Margin of (0.25) %, profit margin of (0.22) %, and Return On Equity of -0.15 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OSE Pharma's price fluctuation is slightly risky at this time. Calculation of the real value of OSE Pharma SA is based on 3 months time horizon. Increasing OSE Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OSE Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OSE Stock. However, OSE Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.54 | Real 5.55 | Hype 6.54 | Naive 7.1 |
The real value of OSE Stock, also known as its intrinsic value, is the underlying worth of OSE Pharma SA Company, which is reflected in its stock price. It is based on OSE Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of OSE Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of OSE Pharma SA helps investors to forecast how OSE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OSE Pharma more accurately as focusing exclusively on OSE Pharma's fundamentals will not take into account other important factors: OSE Pharma Total Value Analysis
OSE Pharma SA is now forecasted to have takeover price of 128.18 M with market capitalization of 104.49 M, debt of 34.77 M, and cash on hands of 33.58 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the OSE Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
128.18 M | 104.49 M | 34.77 M | 33.58 M |
OSE Pharma Investor Information
About 39.0% of the company outstanding shares are owned by corporate insiders. The book value of OSE Pharma was now reported as 2.53. The company recorded a loss per share of 0.41. OSE Pharma SA had not issued any dividends in recent years. Based on the key measurements obtained from OSE Pharma's financial statements, OSE Pharma SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.OSE Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OSE Pharma has an asset utilization ratio of 25.82 percent. This suggests that the Company is making €0.26 for each dollar of assets. An increasing asset utilization means that OSE Pharma SA is more efficient with each dollar of assets it utilizes for everyday operations.OSE Pharma Ownership Allocation
OSE Pharma owns a total of 18.44 Million outstanding shares. OSE Pharma has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.OSE Pharma Profitability Analysis
The company reported the revenue of 26.31 M. Net Loss for the year was (16.85 M) with profit before overhead, payroll, taxes, and interest of 26.31 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates OSE Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in OSE Pharma and how it compares across the competition.
About OSE Pharma Valuation
The stock valuation mechanism determines OSE Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of OSE Pharma. We calculate exposure to OSE Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OSE Pharma's related companies.OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.
8 Steps to conduct OSE Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OSE Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OSE Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OSE Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OSE Pharma's revenue streams: Identify OSE Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OSE Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OSE Pharma's growth potential: Evaluate OSE Pharma's management, business model, and growth potential.
- Determine OSE Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OSE Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |